---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295124636.md"
description: "Xeris Biopharma shares are trading lower after the company reported mixed Q2 financial results."
datetime: "2026-08-06T15:08:26.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295124636.md)
  - [en](https://longbridge.com/en/news/295124636.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295124636.md)
generator: "portal-rs"
---

# 

Xeris Biopharma shares are trading lower after the company reported mixed Q2 financial results.

### Related Stocks

- [XERS.US](https://longbridge.com/en/quote/XERS.US.md)

## Related News & Research

- [XERS: XP-8121 targets a $1-3B market with a 2030 launch, leveraging clinical innovation and strong physician demand](https://longbridge.com/en/news/298461309.md)
- [medmix' Drug Delivery ("Haselmeier") to Support the Development of Xeris Pharmaceuticals' XP-8121 with D-Flex(TM) Pen Injector | MDMXF Stock News](https://longbridge.com/en/news/298551232.md)
- [Xeris Announces Details for XP-8121 Program Overview Webinar | XERS Stock News](https://longbridge.com/en/news/297041149.md)
- [Xeris to host XP-8121 hypothyroidism program overview webinar](https://longbridge.com/en/news/297037117.md)
- [Xeris Biopharma Q2 revenue rises 34%, slightly beats estimates](https://longbridge.com/en/news/295099307.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**